(VIANEWS) – Summit Financial Group (SMMF), Progyny (PGNY), USA Compression Partners, LP (USAC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Summit Financial Group (SMMF)
34.1% sales growth and 14.17% return on equity
Summit Financial Group, Inc. operates as a financial holding company for Summit Community Bank, Inc. that provides community banking and other financial services to individuals and businesses primarily in the Eastern Panhandle, Southern and North Central regions of West Virginia and the Northern, and Shenandoah Valley and Southwestern regions of Virginia, and the Central region of Kentucky. The company's community banking services include demand, savings, and time deposits; commercial, commercial real estate, construction and land development, residential real estate, and consumer loans; and mortgage warehouse lines of credit, as well as trust and wealth management, cash management, and insurance brokerage services. As of December 31, 2020, it operated through 43 banking offices. The company was incorporated in 1987 and is headquartered in Moorefield, West Virginia.
Earnings Per Share
As for profitability, Summit Financial Group has a trailing twelve months EPS of $3.85.
PE Ratio
Summit Financial Group has a trailing twelve months price to earnings ratio of 7.3. Meaning, the purchaser of the share is investing $7.3 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.17%.
Moving Average
Summit Financial Group’s value is higher than its 50-day moving average of $25.76 and way above its 200-day moving average of $22.58.
Sales Growth
Summit Financial Group’s sales growth is 35.3% for the current quarter and 34.1% for the next.
2. Progyny (PGNY)
21% sales growth and 12.06% return on equity
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Progyny has a trailing twelve months EPS of $0.51.
PE Ratio
Progyny has a trailing twelve months price to earnings ratio of 73.35. Meaning, the purchaser of the share is investing $73.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.06%.
3. USA Compression Partners, LP (USAC)
14.5% sales growth and 19.97% return on equity
USA Compression Partners, LP provides natural gas compression services. The company offers compression services to oil companies and independent producers, processors, gatherers, and transporters of natural gas and crude oil, as well as operates stations. It primarily focuses on providing natural gas compression services to infrastructure applications, including centralized natural gas gathering systems and processing facilities, as well as gas lift applications for crude oil wells. As of December 31, 2022, the company had 3,716,854 horsepower in its fleet. USA Compression Partners, LP was founded in 1998 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, USA Compression Partners, LP has a trailing twelve months EPS of $0.15.
PE Ratio
USA Compression Partners, LP has a trailing twelve months price to earnings ratio of 163.93. Meaning, the purchaser of the share is investing $163.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.97%.
4. Great Elm Capital Corp. (GECC)
9.4% sales growth and 14.3% return on equity
Great Elm Capital Corporation is a business development company which specializes in loan and mezzanine, middle market investments. The fund prefers to invest in media, commercial services and supplies, healthcare, telecommunication services, communications equipment. It typically makes equity investments between $3 million and $10 million in companies with revenues between $3 million and $75 million.
Earnings Per Share
As for profitability, Great Elm Capital Corp. has a trailing twelve months EPS of $1.71.
PE Ratio
Great Elm Capital Corp. has a trailing twelve months price to earnings ratio of 6.36. Meaning, the purchaser of the share is investing $6.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.3%.
Volume
Today’s last reported volume for Great Elm Capital Corp. is 15515 which is 16.79% below its average volume of 18647.
Yearly Top and Bottom Value
Great Elm Capital Corp.’s stock is valued at $10.88 at 00:22 EST, under its 52-week high of $11.82 and way above its 52-week low of $7.51.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 50% and 21.6%, respectively.
5. HealthStream (HSTM)
6.2% sales growth and 3.89% return on equity
HealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the range of its clinical development, talent management, training, certification, scheduling, competency assessment, performance appraisal, and other needs, as well as implementation and account management services. It also provides applications for learning, compensation management, succession planning, competency management, disclosure management, simulation-based education, quality management, and industry training. In addition, the company offers VerityStream that delivers enterprise-class solutions to transform the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, medical groups, and other healthcare organizations; EchoCredentialing and MSOW platforms that manage medical staff credentialing, enrollment, and privileging processes for hospitals; and EchoOneApp, a provider enrollment platform for medical groups. Further, it provides CredentialMyDoc, a credentialing and enrollment SaaS solution for medical groups and surgery centers; CredentialStream, a SaaS-based provider credentialing, privileging, and enrollment solution; and NurseGrid Mobile for nurse managers. The company offers its solutions in healthcare industry companies that include private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through direct sales teams. HealthStream, Inc. was incorporated in 1990 and is headquartered in Nashville, Tennessee.
Earnings Per Share
As for profitability, HealthStream has a trailing twelve months EPS of $0.43.
PE Ratio
HealthStream has a trailing twelve months price to earnings ratio of 62.84. Meaning, the purchaser of the share is investing $62.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.89%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 277.02M for the twelve trailing months.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Dec 7, 2023, the estimated forward annual dividend rate is 0.1 and the estimated forward annual dividend yield is 0.37%.
